Vertellus Specialties Reaches Equity Transfer Agreement
INDIANAPOLIS, Nov. 12, 2010 /PRNewswire/ -- Vertellus Specialties Inc. (the "Company"), a leading specialty chemicals company, announced that it will be the acquirer pursuant to an Equity Transfer Agreement reached on November 5, 2010. Further details are available on the Company's Form 8-K posted on the Company's confidential investor website.
About Vertellus Specialties Inc.
Vertellus is a specialty chemicals company focused on the manufacture of ingredients used in pharmaceuticals, personal care, nutrition, agriculture, and a host of other market areas affected by trends favoring "green" technologies and chemistries. Vertellus is the #1 global producer of pyridine and picolines, specialty pyridine derivatives, DEET, castor oil derivatives and systems and the world's #2 producer of Vitamin B-3 and citrate polymer additives. Vertellus benefits from a technically advanced global manufacturing base and has approximately 700 employees. Vertellus is headquartered in Indianapolis, Indiana. Vertellus is owned by Wind Point Partners, a private equity firm based in Chicago. Wind Point acquired Vertellus in 2007 through Wind Point VI, a $715 million fund. Further information is available at www.vertellus.com.
Contact: David Schwind |
|
Vertellus Specialties |
|
317-248-6478 |
|
Roland Tomforde |
|
Broadgate Consultants |
|
212-232-2222 |
|
SOURCE Vertellus Specialties Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article